Hospital-acquired infection outbreak thresholds: Difference between revisions
From IDWiki
m (Aidan moved page Infection Prevention and Control Outbreak thresholds to Hospital-acquired infection outbreak thresholds without leaving a redirect) |
m (Formatted links) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | {| class="wikitable" |
||
| − | = Outbreak thresholds = |
||
| + | ! Organism !! Definition !! Incubation !! Point prevalence testing |
||
| − | |||
| − | {| |
||
| − | ! Organism |
||
| − | ! Definition |
||
| − | ! Incubation |
||
| − | ! Point prevalence testing |
||
|- |
|- |
||
| + | | [[Enterococcus species|VRE]] |
||
| − | | VRE |
||
| 3 noso cases in 7 days, or 5 in 28 days |
| 3 noso cases in 7 days, or 5 in 28 days |
||
| — |
| — |
||
| Test 3 days, 3 days, and 7 days |
| Test 3 days, 3 days, and 7 days |
||
|- |
|- |
||
| + | | [[Staphylococcus aureus|MRSA]] |
||
| − | | MRSA |
||
| As above |
| As above |
||
| — |
| — |
||
| Line 22: | Line 17: | ||
| Weekly or at discretion of ICP |
| Weekly or at discretion of ICP |
||
|- |
|- |
||
| − | | C. difficile |
+ | | [[Clostridioides difficile|''C. difficile'']] |
| For >20 beds: 3 noso cases in 7 days, or 5 in 28 days<br/>For <20 beds: 2 noso cases in 7 days, or 4 in 28 days |
| For >20 beds: 3 noso cases in 7 days, or 5 in 28 days<br/>For <20 beds: 2 noso cases in 7 days, or 4 in 28 days |
||
| — |
| — |
||
| Line 32: | Line 27: | ||
| Ongoing syrveillance for symptomatic patients and staff |
| Ongoing syrveillance for symptomatic patients and staff |
||
|- |
|- |
||
| − | | Norovirus |
+ | | [[Norovirus]] |
| 2-3 noso cases |
| 2-3 noso cases |
||
| 2 days |
| 2 days |
||
| Ongoing surveillance for symptomatic patients and staff |
| Ongoing surveillance for symptomatic patients and staff |
||
|- |
|- |
||
| − | | Scabies |
+ | | [[Sarcoptes scabiei|Scabies]] |
| 1-2 noso cases |
| 1-2 noso cases |
||
| 6 weeks |
| 6 weeks |
||
| Ongoing surveillance for symptomatic patients and staff |
| Ongoing surveillance for symptomatic patients and staff |
||
|} |
|} |
||
| + | |||
| + | [[Category:Infection prevention and control]] |
||
Latest revision as of 09:40, 31 October 2019
| Organism | Definition | Incubation | Point prevalence testing |
|---|---|---|---|
| VRE | 3 noso cases in 7 days, or 5 in 28 days | — | Test 3 days, 3 days, and 7 days |
| MRSA | As above | — | Weekly or at discretion or ICP |
| Other ARO | As above | — | Weekly or at discretion of ICP |
| C. difficile | For >20 beds: 3 noso cases in 7 days, or 5 in 28 days For <20 beds: 2 noso cases in 7 days, or 4 in 28 days |
— | Ongoing surveillance for symptomatic patients |
| Respiratory viruses | 2+ noso cases within 48 hours on a single unit, confirmed as the same pathogen Consider enhanced monitoring if only one case was confirmed by the lab |
3 days | Ongoing syrveillance for symptomatic patients and staff |
| Norovirus | 2-3 noso cases | 2 days | Ongoing surveillance for symptomatic patients and staff |
| Scabies | 1-2 noso cases | 6 weeks | Ongoing surveillance for symptomatic patients and staff |
